pros and cons of glp-1 agonist Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) receptor agonists (semaglutide [Wegovy, Ozempic, Rybelsus]) dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind pros and cons of glp
Pay in 4 interest-free payments of $6.38 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
![pros and cons of glp-1 agonist Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) receptor agonists (semaglutide [Wegovy, Ozempic, Rybelsus]) dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind pros and cons of glp](https://www.diabetesincontrol.com/wp-content/uploads/2025/07/compressed_glp1_infographic.jpg)
![pros and cons of glp-1 agonist Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) receptor agonists (semaglutide [Wegovy, Ozempic, Rybelsus]) dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind pros and cons of glp](https://post.healthline.com/wp-content/uploads/2023/03/male-with-injector-pen-732-549-header.jpg)
![pros and cons of glp-1 agonist Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) receptor agonists (semaglutide [Wegovy, Ozempic, Rybelsus]) dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind pros and cons of glp](https://aultman.org/assets/Healthier-Together/GLP-1-2.png)
![pros and cons of glp-1 agonist Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) receptor agonists (semaglutide [Wegovy, Ozempic, Rybelsus]) dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind pros and cons of glp](https://www.wth.org/wp-content/uploads/2025/05/GettyImages-2200929782-scaled.jpg)
![pros and cons of glp-1 agonist Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) receptor agonists (semaglutide [Wegovy, Ozempic, Rybelsus]) dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind pros and cons of glp](https://imgctf--assets.ro.co/jj2wf7627pjc/2LLM8wFIVK8qp78OgXGV65/ae3ebcd72703e3f46c817a3cda4013c2/Ro_March_GLP-1_Agonists_Explained_Graphic_3.png?fm=webp&q=80&w=2560)



















